ULTRAGENYX (RARE) JUMPED 7.5% ON FDA APPROVAL. CAN A $2.7 MILLION GENE THERAPY BECOME A COMMERCIAL SUCCESS? - YAHOO

FDA approval catalyst drove 7.5% jump, but $2.7 million price raises commercial viability questions.